Healthcare

Acknowledged for our partnership style, we bring our investment expertise, sector insight and relationships to build lasting value within healthcare businesses across Europe, Asia and the Americas.

Since April 2001, 3i has invested €1.8bn in 37 healthcare companies internationally.

We invest in three core sub-sectors:

• Pharmaceuticals and biotechnology: Within this wide-ranging sector, we see opportunities in these key areas: Specialty Pharma, Generics / OTC, Drug Delivery and Animal Health.
• Healthcare Services: This is the largest and most rapidly-evolving sub-sector within the global healthcare industry and includes activities such elderly and specialty care, including for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support and clinical services and B2B contract services. 
• Medical devices and technology: This sub-sector deals with a range of devices, medical equipment and consumables, diagnostics and healthcare IT encompassing a means to identify the nature of health conditions and to allow intervention with methods that increase life span and/or improve the quality of care and life.

Across the world, the upward trend in healthcare spending is relentless, driven by powerful and enduring factors: ageing populations in Europe and the Americas, rising affluence in Asia, and a widespread mindset that expects every new treatment to be instantly available.

These fundamental drivers of growth make healthcare a resilient and compelling sector for investors, especially at times of global uncertainty. Therefore, of particular interest are products and services which help to drive cost out of the provision of healthcare in parallel with improving the quality of service.

At 3i, our team of Healthcare professionals have an on-the-ground presence in three continents and a strong network of experts at the large corporate healthcare providers, clinicians and policy-makers. By taking a global view of trends and migrating innovation to where it is needed, we are playing a strong part in building efficient, international healthcare businesses.